Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-04-18
1989-06-13
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 51, A61K 31475, C07D46100
Patent
active
048393622
ABSTRACT:
The invention relates to the preparation of cis and trans stereoisomers of racemic and optically active eburnamenine derivatives of the general formula (Ia) ##STR1## or (Ib), ##STR2## wherein R.sub.1 stands for a C.sub.1-4 alkyl group; and
REFERENCES:
patent: 3925392 (1975-12-01), Najer et al.
patent: 3987049 (1976-10-01), Plat et al.
patent: 4057550 (1977-11-01), Szantay et al.
patent: 4065458 (1977-12-01), Lorincz et al.
patent: 4120858 (1978-10-01), Clauder et al.
patent: 4474960 (1984-10-01), Szantay et al.
Toth, et al., Chemical Abstracts, vol. 93:239740y (1980).
Czira, et al., Chemical Abstracts, vol. 102:185332a (1985), Abstract of Org. Mass. Spectrom., 1984, 19(11), pp. 555-562.
Chemical Abstracts, 1982-1986 Chem. Substance Index, p. 24693CS.
Csomor Katalin
Czibula Laszlo
Farkas nee Kirjak Maria
Forgacs Lilla
Gere Aniko
Dubno Herbert
Myers Jonathan
Richter Gedeon Vegyeszeti Gyar Rt.
Rivers Diana G.
Sutto Anton H.
LandOfFree
Eburnamenine derivatives, pharmaceutical compositions and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eburnamenine derivatives, pharmaceutical compositions and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eburnamenine derivatives, pharmaceutical compositions and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1277891